• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

SEC Hits Allarity With Wells Notice, Flags Alleged Violations in FDA Meeting

cafead

Administrator
Staff member
  • cafead   Jul 23, 2024 at 11:42: AM
via Allarity Therapeutics announced Monday that the Securities and Exchange Commission has made a preliminary determination recommending an enforcement action against the company for alleged violations of federal securities laws.

article source